Related references
Note: Only part of the references are listed.2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NM CNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
HYPERTENSION (2018)
Discovery of highly potent renin inhibitors potentially interacting with the S3′ subsite of renin
Xiaowei Sun et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Recent progress on the discovery of non-peptidic direct renin inhibitors for the clinical management of hypertension
Fumiaki Yokokawa
EXPERT OPINION ON DRUG DISCOVERY (2013)
Optimization of orally bioavailable alkyl amine renin inhibitors
Zhenrong Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Direct Renin Inhibitors as a New Therapy for Hypertension
Randy L. Webb et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Design and Preparation of Potent, Nonpeptidic, Bioavailable Renin Inhibitors
Olivier Bezencon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Clinical pharmacokinetics and pharmacodynamics of Aliskiren
Sujata Vaidyanathan et al.
CLINICAL PHARMACOKINETICS (2008)
Recent advances in the discovery of non-peptidic direct renin inhibitors as anti hypertensives: new patent applications in years 2000-2008
Fumiaki Yokokawa et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2008)
Aliskiren combined with losartan in type 2 diabetes and nephropathy
Hans-Henrik Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial
Suzanne Oparil et al.
LANCET (2007)
Renin inhibition with aliskiren: where are we now, and where are we going?
M Azizi et al.
JOURNAL OF HYPERTENSION (2006)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Piperidine renin inhibitors: from leads to drug candidates
HP Marki et al.
FARMACO (2001)
Structure-based drug design:: the discovery of novel nonpeptide orally active inhibitors of human renin
J Rahuel et al.
CHEMISTRY & BIOLOGY (2000)
Share Paper
